Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sporadic postinfectious neuromyasthenia.

I E Salit

    CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Sporadic neuromyasthenia, characterized by prolonged fatigue after infection, affects active women. While physical exams and labs are often normal, identifying the cause remains challenging, with supportive therapy showing benefit.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Human and canine blastomycosis: A common source infection.

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
    Same author

    Post-infectious fatigue.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    The HIV-positive dentist: balancing the rights of the health care worker and the patient.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2001
    Same author

    Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1999
    Same author

    Iritis associated with intravenous cidofovir.

    The Annals of pharmacotherapy·1999
    Same author

    Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.

    AIDS (London, England)·1998

    Area of Science:

    • Neurology
    • Infectious Diseases
    • Epidemiology

    Background:

    • Epidemic neuromyasthenia outbreaks are known globally.
    • Sporadic cases of neuromyasthenia have only recently been identified and investigated.
    • This condition is characterized by prolonged and excessive fatigue following an acute infection.

    Purpose of the Study:

    • To investigate the characteristics of 50 consecutive patients with sporadic neuromyasthenia.
    • To identify potential causative agents and understand the clinical presentation and course of the illness.
    • To evaluate the effectiveness of different therapeutic approaches.

    Main Methods:

    • Prospective investigation of 50 patients presenting with prolonged fatigue post-infection.
    • Detailed clinical assessment including patient history, physical examination, and laboratory testing.

    Related Experiment Videos

  • Etiological investigation including viral, parasitic, and bacterial testing.

    • Main Results:

    • The study population primarily consisted of well-educated, active, unmarried women aged 30-40 years.
    • Common findings included normal physical examinations and laboratory results.
    • Identified potential triggers in some patients: Epstein-Barr virus (16), other viruses (7), parasites (4), and Mycoplasma pneumoniae (2). The cause was unknown in 22 cases.
    • The mean illness duration was 27.6 months, with an average of 39% time lost from work or school.
    • Drug therapy was ineffective, while supportive therapy proved beneficial.

    Conclusions:

    • Sporadic neuromyasthenia presents with persistent fatigue after infection, often with normal diagnostic findings.
    • Epstein-Barr virus and other infectious agents may play a role, but the etiology remains unclear in many cases.
    • Optimal management requires further investigation, with supportive care being a key component of current treatment.